Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Bohdan, Huszno"'
Autor:
Elwira Przybylik-Mazurek, Zbigniew Szybiński, Małgorzata Trofimiuk, R. Wasik, Mariusz Klencki, Elżbieta Bandurska-Stankiewicz, Andrzej Lewiński, Leszek Szewczyk, Bohdana Dorant, Ewa Bar-Andziak, M. Rybakowa, I Kinalska, Bohdan Huszno, Monika Buziak-Bereza, Filip Gołkowski, Jerzy Sowiński, Lucjan Szponar
Publikováno v:
Journal of Endocrinological Investigation. 31:309-313
Objective: Most of the Polish territory has been classified as an iodine-deficient and endemic goiter area according to the International Council for Control of Iodine Deficiency (ICCIDD) criteria. In 1997 the obligatory model of iodine prophylaxis w
Autor:
Agata Bałdys-Waligórska, Filip Gołkowski, P. Łopatka, Bohdan Huszno, Ryszard Czepko, Monika Buziak-Bereza, Dariusz Adamek, Małgorzata Trofimiuk
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 115:537-540
Pituitary metastases, though very uncommon, may cause endocrine and neurosurgical problems. The clinical manifestation of such metastases is highly variable. Most of the metastatic pituitary tumours are oligosymptomatic. We report two cases of metast
Autor:
Krzysztof Okoń, Agnieszka Stefańska, Robert Chrzan, Filip Gołkowski, Bohdan Huszno, Andrzej Urbanik, Monika Buziak-Bereza, Agata Bałdys-Waligórska, Andrzej Budzyński
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 115:401-404
UNLABELLED Adrenocortical oncocytoma is extremely rarely found. Only a little more than thirty cases of adrenal oncocytoma, mainly nonfunctioning and benign, have been reported in the literature. Adrenal mass 150 x 160 x 172 mm in size and enlarged p
Autor:
Marcin Barczyński, Martin K. Walz, Filip Gołkowski, Stanisław Cichoń, K. Peitgen, Bohdan Huszno, Aleksander Konturek
Publikováno v:
World Journal of Surgery. 31:65-71
Today, the posterior retroperitoneoscopic technique has become a standard procedure in adrenal surgery. The procedure allows direct access to the adrenal glands, but it seems to be difficult because of the uncommon anatomic view. This study compares
Autor:
Alicja Hubalewska-Dydejczyk, Aleksander Konturek, Marcin Barczyński, Zbigniew Szybiński, Bohdan Huszno, Monika Buziak-Bereza, Filip Gołkowski, Stanisław Cichoń
Publikováno v:
Clinical Endocrinology. 65:106-113
Summary Objective To determine the sensitivity and positive predictive value (PPV) of subtraction scintigraphy (SS) vs. ultrasonography (US) of the neck combined with rapid intact parathyroid hormone (iPTH) assay in US-guided fine-needle parathyroid
Autor:
R. Wasik, Leszek Szewczyk, T Zak, Malgorzata Karbownik, Andrzej Lewiński, Bohdan Huszno, Filip Gołkowski, F Delange, J Podoba, I Kinalska, Elwira Przybylik-Mazurek, Zbigniew Szybiński, Małgorzata Trofimiuk, J Pantoflinski, Rybakowa M
Publikováno v:
European Journal of Endocrinology. :331-337
BACKGROUND: Iodine prophylaxis in Poland started in 1935 and has been interrupted twice: by World War II and in 1980 for economic reasons. Epidemiological surveys carried out after the Chernobyl accident in 1989 as well as in 1992/1993 and in 1994 as
Publikováno v:
Przeglad lekarski. 65(12)
Obesity is an effect of interaction of genetic and environmental factors. It leads to development of serious complications, like insulin resistance, diabetes type 2, arterial hypertension and atherosclerosis. The adipose tissue is a place where many
Autor:
Alicja, Hubalewska-Dydejczyk, Wojciech, Jurczak, Anna, Sowa-Staszczak, Jolanta, Kunikowska, Leszek, Królicki, Aleksandra, Gilis-Januszewska, Agnieszka, Giza, Magdalena, Szurkowska, Dorota, Pach, Bogusław, Głowa, Renata, Mikołajczak, Dariusz, Pawlak, Agnieszka, Stefańska, Bohdan, Huszno, Aleksander B, Skotnicki
Publikováno v:
Nuclear medicine review. CentralEastern Europe. 11(1)
Currently, there is growing interest in the use of the beta emitter (90)Y in systemic therapy in oncology. For successful therapy, an appropriate ligand is chosen to carry the isotope to the place of its action. As well as performing this function, t
Autor:
Wojciech, Jurczak, Alicja, Hubalewska-Dydejczyk, Agnieszka, Giza, Anna, Sowa-Staszczak, Bohdan, Huszno, Aleksander B, Skotnicki
Publikováno v:
Nuclear medicine review. CentralEastern Europe. 10(2)
Ibritumomab, an (90)Yttrium ((90)Y) labelled radioimmunoconjugate, is registered in Europe to treat follicular lymphomas. Its mode of action combines the selectivity of monoclonal antibodies with the efficiency of radiotherapy, making it a unique and
Autor:
Wojciech, Jurczak, Alicja, Hubalewska-Dydejczyk, Agnieszka, Giza, Anna, Sowa-Staszczak, Tomasz, Wróbel, Grzegorz, Mazur, Piotr, Boguradzki, Wanda, Knopińska-Posłuszny, Bohdan, Huszno, Aleksander B, Skotnicki
Publikováno v:
Nuclear medicine review. CentralEastern Europe. 10(2)
Ibritumomab is an (90)Yttrium ((90)Y) labelled radioimmunoconjugate registered to treat follicular lymphoma relapsing or refractory after Rituximab therapy. Combining the specificity of anti CD20 monoclonal antibodies with the efficacy of radiotherap